Table 1.
Treatment options for patients with TE post-COVID-19.
No. | Authors | Years | Number of Patients | Treatment Options |
---|---|---|---|---|
1. | Ohyama et al. [1] | 2022 | Meta-analysis | Oral or topical minoxidil Oral supplements with biotin, iron, and vitamin D Iontophoresis with growth factors Microneedles |
2. | Hussain et al. [19] | 2022 | 465 (meta-analysis) | Oral supplements with sulfur amino acid/vitamin B6, iron, and vitamin D |
3. | Saki et al. [49] | 2022 | 1 | Oral supplements with vitamin D3 Intramuscular biotin |
4. | Lv et al. [50] | 2022 | 1 | Topical minoxidil 5% Topical halcinonide lotion Shampoo with selenium sulfide |
5. | Olds et al. [48] | 2021 | 10 | Oral supplements with biotin, iron, and vitamin D Topical minoxidil 5% Topical corticosteroids |
6. | Rizzeto et al. [51] | 2021 | 3 | Oral supplements with sulfur amino acid/vitamin B6 Topical peptide (hair growth factor-like) Topical minoxidil 5% |
7. | Rossi et al. [4] | 2021 | 14 | Oral supplements with biotin, alpha-lipoic acid, iron, vitamin D3 and B5, and topical corticosteroids |
8. | Starace et al. [42] | 2021 | 128 | Oral supplements with amino acids and vitamins Topical corticosteroids Topical minoxidil Topical hair growth promoters |
9. | Moreno-Arrones et al. [36] | 2020 | 214 (meta-analysis) | Oral or topical minoxidil (2% or 5%) Oral supplements Platelet-rich plasma treatment |